SLC22A1 transports Cipro into renal cell

Stable Identifier
R-HSA-9794523
Type
Reaction [transition]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Because of its high renal clearance, ciprofloxacin (Cipro) is probably not reabsorbed by renal tubular cells. In addition to glomerular secretion, Cipro is also secreted contraluminally by tubular cells (reviewed by Sörgel & Kinzig, 1993). The first step of contraluminal tubular secretion consists of facilitated transport of Cipro by SLC22A1 (OCT1) through the basolateral parts of the membrane (Mulgaonkar et al, 2013). In rat, facilitated basolateral transport by Slc47a1 (rMATE1) has been shown (Ohta et al, 2009).
Literature References
PubMed ID Title Journal Year
8383921 Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions

Kinzig, M, Sörgel, F

Am J Med 1993
23545524 Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials

Gründemann, D, Venitz, J, Mulgaonkar, A, Sweet, DH

Antimicrob Agents Chemother 2013
Participants
Participates
Catalyst Activity

organic cation transmembrane transporter activity of SLC22A1 [basolateral plasma membrane]

Orthologous Events
Authored
Reviewed
Created
Cite Us!